Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's disease.
about
Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer's disease model.Why Are CASTA and CARS Results Different? Analysis of CASTA Data from Korea and Hong Kong.ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD.APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesisA neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis.Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.Molecular mechanisms of neurodegeneration in Alzheimer's disease.Adult neurogenesis: integrating theories and separating functions.Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure.Current and emerging drug treatment options for Alzheimer's disease: a systematic review.Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesisNeurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin.Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic RatsModulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease.Microglial VPAC1R mediates a novel mechanism of neuroimmune-modulation of hippocampal precursor cells via IL-4 release.Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathiesImpaired neurogenesis by HIV-1-Gp120 is rescued by genetic deletion of fatty acid amide hydrolase enzyme.Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) Reduces Neurodegeneration and Increases Neural Precursor Cell Proliferation in a Mouse Model of Alzheimer Disease.Novel strategies for Alzheimer's disease treatment.Pharmacological Treatment of Alzheimer's Disease: Is it Progressing Adequately?Neurotrophic effects of Cerebrolysin in the Mecp2(308/Y) transgenic model of Rett syndromeThe cannabinoid CB₂ receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis.Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before.Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease.Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats.Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke.Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease.Regional comparison of the neurogenic effects of CNTF-derived peptides and cerebrolysin in AβPP transgenic mice.Combined administration of cerebrolysin and donepezil induces plastic changes in prefrontal cortex in aged mice.Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease.Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice.2nd International Salzburg Conference on Neurorecovery (ISCN 2013) Salzburg/Austria|November 28th-29th, 2013.Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin.Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of Parkinson's Disease.Intrahippocampal injection of Aβ1-42 inhibits neurogenesis and down-regulates IFN-γ and NF-κB expression in hippocampus of adult mouse brain.Impaired spatial working memory after anterior thalamic lesions: recovery with cerebrolysin and enrichment.
P2860
Q27316651-12FD2DD9-6261-4E6C-B7CB-B8ACC7283802Q31095168-AA3822F7-7ACD-4275-AF05-E9638CA05202Q33733667-D8F49A70-1610-4010-9443-18D0DE720698Q33759956-369C2320-3642-4300-BABF-46783EE32760Q33793059-4A8375C8-52E2-467D-86AE-A617F5D8EC66Q33828868-D1BCC61A-F5EE-4C51-9DA0-EA23120382A1Q33871297-C734F45C-45F6-4354-BF86-5FDD4C4BF92BQ33998531-6049FEF3-69D3-4DDE-9D32-87CB8CD3AB48Q34006701-08D411A3-2BB2-46A1-B45E-CFB6073A31D1Q34222721-6D697A66-E224-4294-953B-23D660F49E16Q34299878-4F5E4BAB-3C82-444D-AE90-C82D34234635Q34629320-CCF53C24-871C-49C8-94CC-D2804E05A7FEQ34804269-6937F7C1-8873-4FF7-AD01-78A0ACB231DDQ35006021-18D5C5FC-3020-4E3A-82DB-16A5BE8889CDQ35107951-26157054-A2CA-463E-A298-477DF33DAD64Q35854093-025EAAFD-0523-4769-9232-6CBE173E02C3Q36124206-1B40C009-31B6-48B2-B7DF-705CC1BA7DB3Q36489317-264D2352-351D-4F72-9196-D294944CAE2AQ37012066-5ECC23D5-7BAC-4E69-B764-FCCF6EE1551FQ37198579-474CEBE1-9D85-4BD9-A8B4-A39B8C17C417Q37319332-46D3B41A-2A5A-4D73-90B0-060C40460B47Q37522883-C113CFA9-EC11-4D32-A9A2-6DD802BCC829Q37910243-ED4558DB-12BE-4E85-8376-68B39749748CQ38381854-D1837872-076F-47D8-A690-C6712192D284Q39203644-D823B860-9C9F-481B-A4F9-D671B62D96F0Q41774025-65D0B7A9-953B-4240-951A-3C17EF658A92Q41832273-2BC37D68-D745-4FFD-88AC-210B2D44413CQ41958340-29689DFE-DB36-4AA5-ACE8-B91309741DE7Q42510029-77AF64E5-1F83-4492-A4E8-B04BC1143B7FQ42515963-1437A417-B030-430F-A507-BB2B4838547CQ42989221-E0B13951-A484-4AD9-AAFE-868EE7983F91Q43130428-7099331E-E80A-4776-BCDF-1672C43D37DEQ45866665-FDCB628D-6512-479C-9B2F-E9A12ABA15CDQ47755717-AC578A4C-E9DC-49DD-BDBF-AF6D538F8B8CQ48226595-650419C8-4A1A-4DB9-820E-27BB5B7CABA9Q48304931-034E46F8-7421-45D7-8800-D8F1C25E0664
P2860
Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Effects of Cerebrolysin on neu ...... model of Alzheimer's disease.
@en
Effects of Cerebrolysin on neu ...... model of Alzheimer's disease.
@nl
type
label
Effects of Cerebrolysin on neu ...... model of Alzheimer's disease.
@en
Effects of Cerebrolysin on neu ...... model of Alzheimer's disease.
@nl
prefLabel
Effects of Cerebrolysin on neu ...... model of Alzheimer's disease.
@en
Effects of Cerebrolysin on neu ...... model of Alzheimer's disease.
@nl
P2093
P2860
P1476
Effects of Cerebrolysin on neu ...... model of Alzheimer's disease.
@en
P2093
Anthony Adame
Herbert Moessler
Leslie Crews
Michael Mante
P2860
P2888
P304
P356
10.1007/S00401-006-0166-5
P577
2006-11-28T00:00:00Z